Target Details
| UniProt AC | P22607 |
|---|---|
| Gene Symbol | FGFR3 |
| Protein Name | Fibroblast growth factor receptor 3 |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF21165 (FGFR3_TM) PF07679 (I-set) PF13927 (Ig_3) PF07714 (PK_Tyr_Ser-Thr) |
Summary
- Multi-target molecules 2,742
- Clinical molecules 64
- Avg pChEMBL 7.75
KEGG Pathways (13)
- Bladder cancer
- Calcium signaling pathway
- Central carbon metabolism in cancer
- EGFR tyrosine kinase inhibitor resistance
- Endocytosis
- MAPK signaling pathway
- MicroRNAs in cancer
- PI3K-Akt signaling pathway
- Pathways in cancer
- Rap1 signaling pathway
- Ras signaling pathway
- Regulation of actin cytoskeleton
- Signaling pathways regulating pluripotency of stem cells
Associated Diseases (15)
- Achondroplasia
- Bladder cancer
- CATSHL syndrome
- Colorectal cancer
- Crouzon syndrome
- Epidermal nevus
- FGFR3-related short limb skeletal dysplasia
- Hypochondroplasia
- Lacrimo-auriculo-dento-digital syndrome
- Muenke syndrome
- Multiple myeloma
- SADDAN
- Syndromic craniosynostoses
- Testicular cancer
- Thanatophoric dysplasia
Active Molecules (2,742)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
LMRHQCUBZFIJGM
|
9.2 | IC50 | 2 | — | |
PRXXXHCKGRNFLJ
|
9.2 | IC50 | 8 | — | |
SATSIBBDXBFFRY
|
9.2 | IC50 | 2 | — | |
SATSIBBDXBFFRY
|
9.2 | IC50 | 2 | — | |
OWFCRBSDJKZKBD
|
9.2 | IC50 | 5 | — | |
OYHDEFFNZNIKPS
|
9.2 | IC50 | 5 | — | |
FDYYKFWGYGBXLY
|
9.2 | IC50 | 4 | — | |
LOGILNXSZVJESJ
|
9.2 | IC50 | 2 | — | |
WXAXVITWIABKBN
|
9.2 | IC50 | 5 | — | |
XEIJGSZLPPJMDB
|
9.2 | IC50 | 2 | — | |
XEIJGSZLPPJMDB
|
9.2 | IC50 | 2 | — | |
SYYWXUPQJHTGCG
|
9.2 | IC50 | 2 | — | |
AHAHQLJJHZPGFT
|
9.2 | IC50 | 5 | — | |
DLAWFXCKIUSOJX
|
9.2 | IC50 | 2 | — | |
FVBYZAPHBUXFOH
|
9.2 | IC50 | 2 | — | |
GCAGOMTVWIYPLE
|
9.2 | IC50 | 2 | — | |
GIGKUNDIEURVLE
|
9.2 | IC50 | 2 | — | |
GUXJNJORIXUBRE
|
9.2 | IC50 | 4 | — | |
KFKYFVCBOAGDTP
|
9.2 | IC50 | 3 | — | |
LNCJTAGAWGYDHX
|
9.2 | IC50 | 2 | — | |
NFYDPTASEPAEMT
|
9.2 | IC50 | 4 | — | |
NRTLSZJUKLLLCA
|
9.2 | IC50 | 2 | — | |
YTDWYXQAKOWNAV
|
9.2 | IC50 | 3 | — | |
YTDWYXQAKOWNAV
|
9.2 | IC50 | 4 | — | |
FMGRQWRWTCYNKA
|
9.1 | IC50 | 5 | — | |
QXEIBRXBXUDRBY
|
9.1 | IC50 | 2 | — | |
UCEBVYASTURHJB
|
9.1 | IC50 | 2 | — | |
UCEBVYASTURHJB
|
9.1 | IC50 | 2 | — | |
CCUFQMNJWSZJOM
|
9.1 | IC50 | 2 | — | |
FUJRLCGRVNAIMR
|
9.1 | IC50 | 2 | — | |
QQOOENCAPIWETQ
|
9.1 | IC50 | 2 | — | |
SUOJOMRSEWHNNR
|
9.1 | IC50 | 2 | — | |
WQBYXCPGODMRBD
|
9.1 | IC50 | 2 | — | |
AJNWCFOYJHPQFV
|
9.1 | IC50 | 2 | — | |
LEXLDXIEJNLCIZ
|
9.1 | IC50 | 2 | — | |
WAJZYUMMTDBTGH
|
9.1 | IC50 | 2 | — | |
TXNNORIVSOVTRM
|
9.1 | IC50 | 2 | — | |
CVTLXZHZCMNAPK
|
9.1 | Kd | 3 | — | |
YUBNVBSTUSZFME
|
9.1 | IC50 | 2 | — | |
AEQRLIJNBCKCJO
|
9.1 | IC50 | 2 | — | |
PVLAKZNIDMGUHQ
|
9.1 | IC50 | 2 | — | |
VSDZEHDPNRWKLG
|
9.1 | IC50 | 6 | — | |
XHBILJGMHZEZKH
|
9.1 | IC50 | 2 | — | |
YISJWEXLNFHRNW
|
9.1 | IC50 | 4 | — | |
ZZWQREKFRLSPQU
|
9.1 | IC50 | 6 | — | |
JYQPFNMDHXKRKL
|
9.0 | IC50 | 5 | — | |
MHKDNJZDYJPDJU
|
9.0 | IC50 | 2 | — | |
NBZBEZQNNHINQM
|
9.0 | IC50 | 2 | — | |
GUHZQOUGERIFMY
|
9.0 | IC50 | 5 | — | |
YYEPRQYYBGHDEV
|
9.0 | IC50 | 2 | — |